Recent Updates
Recently added Catalysts
FENC

University Avenue, 8th floor Date

Key Takeaway: 100 University Avenue, 8th floor Date: April 18, 2019 Toronto ON, M5J 2Y1 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: FENNEC PHARMACEUTICALS INC. We advise of the following with respect to the upcoming Meeting of Security Holders for the

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
22.8%
average across 3 past catalysts
Lead asset
ADH-1
Phase 2 · Neoplasms

Full Press Release Details

100 University Avenue, 8th floor
Date: April 18, 2019 Toronto ON, M5J 2Y1
www.computershare.com
To: All Canadian Securities Regulatory Authorities
Subject: FENNEC PHARMACEUTICALS INC.
We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:
Meeting Type : Annual General and Special Meeting
Record Date for Notice of Meeting : May 14, 2019
Record Date for Voting (if applicable) : May 14, 2019
Beneficial Ownership Determination Date : May 14, 2019
Meeting Date : June 18, 2019
Meeting Location (if available) : New York, NY
Issuer sending proxy related materials directly to NOBO: No
Issuer paying for delivery to OBO: Yes
Notice and Access (NAA) Requirements:
NAA for Beneficial Holders No
NAA for Registered Holders No
Voting Security Details:
Description CUSIP Number ISIN
COMMON SHARES 31447P100 CA31447P1009
Agent for FENNEC PHARMACEUTICALS INC.
Last updated: Apr 18, 2019